Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...
The FDA has approved Bracco’s gadopiclenol-based contrast agent, Vueway, for IV MRI imaging in neonates and infants. Vueway is a macrocyclic gadolinium-based contrast agent that delivers effective ...
CORVALLIS, Ore. (KTVZ) -– Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents ...
Bayer submitted an application to the U.S.'s Food and Drug Administration to get approval for its gadoquatrane agent, a substance used to improve the quality of magnetic resonance imaging scans. The ...
In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging ...
Japan MHLW approves Bayer’s low-dose MRI contrast agent, Ambelvist: Berlin Wednesday, March 25, 2026, 11:00 Hrs [IST] Bayer announced the world’s first approval of the MRI con ...
Preclinical evaluation of 64Cu-labeled cetuximab in immuno-PET for detecting sentinel lymph node metastasis in epidermal growth factor receptor–positive breast cancer. This is an ASCO Meeting Abstract ...
The Medicines Control Authority of Zimbabwe has issued a public safety alert following a voluntary recall of Urografin 60%, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results